V
Viva Biotech
Sustainability Report and Carbon Intensity Rankings
Is Viva Biotech doing their part?
Their DitchCarbon score is 30
Viva Biotech has a DitchCarbon Score of 30 out of 100, indicating a lower performance in sustainability measures. This score suggests that the company has a relatively high carbon intensity compared to more sustainable peers. Viva Biotech may need to implement more effective strategies to reduce its carbon footprint and improve its sustainability efforts.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Viva Biotech operates in the health and social services industry, which has a low carbon intensity ranking. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Unknown
High
Very high
Viva Biotech operates in China, a region with a certain carbon intensity rating that influences the company’s environmental impact. The sustainability of Viva Biotech’s operations is partially dependent on China’s efforts to manage its carbon emissions.
Unlock 30+ emissions data points on Viva Biotech
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Viva Biotech
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
11.56%
...this company is doing 11.56% worse in emissions than the industry average.
Founded in 2006 and based in Shanghai, China, Viva Biotech operates in the health and social services industry as a collaboration Contract Research Organization (CRO) specializing in preclinical drug discovery. The company offers a comprehensive range of services including gene-to-structure studies, in vitro and in vivo assays, and animal model development, catering to both large pharmaceutical companies and small to medium-sized businesses. With a strong focus on structural biology and protein science, Viva Biotech distinguishes itself in the market by continuously enhancing its technological capabilities and expanding its service offerings.
emission intelligence's platform recommendations for Viva Biotech
Viva Biotech should consider implementing green procurement policies to source low-carbon energy and services, which could potentially reduce their emissions by 30%.
Bad news, Viva Biotech hasn't committed to SBTi goals yet
Viva Biotech has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is either in the process of setting their emissions reduction targets or has not yet taken the formal steps to align with SBTi’s criteria and recommendations.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.